What's New at Inagene
Finding what works for you and your unique body is important. In this blog post, we will outline different strategies one can take to optimize their own personal health journey.
Real-life patient experience demonstrates the positive impact of pharmacogenetic (PGx) testing on patients suffering with pain and mental health conditions
Only one in three people prescribed antidepressants or pain medication find an effective treatment on the first try. Not finding the right medication can have dire consequences. The study recruited 50 patients being treated for chronic pain and mental health conditions.
Inagene CEO Nancy White is joined by Jane Sarasohn-Kahn to discuss post-pandemic health trends including health economics, the echo-pandemic and technologies that are shaping a holistic approach to care.
A partnership in innovation: Calian Group and Inagene Diagnostics partner to change the lives of Canadians suffering from mental health and pain conditions.
Calian Group Ltd., one of Canada's largest national health services organizations, supported a ground-breaking pilot study by Inagene Diagnostics in late 2020 to evaluate the “real-life” value of pharmacogenetic testing in optimizing the treatment of chronic pain and mental health conditions. Fifty Canadians who were being treated for chronic pain and concurrent mental health conditions were recruited from a busy clinic in PEI for the study in late 2020 to evaluate the impact pharmacogenetic testing could have on treatment, and on the time and cost burden involved in trialing different medications. The results were compelling and validated outcomes from previous studies.
On May 13th, Global News Health Matters segment featured Inagene and Pharmacogenetic testing (PGx), helping to bring awareness to how this new science is revolutionizing the way drugs are prescribed, and empowering Canadians living with mental health conditions to move beyond the antiquated “trial and error” method of finding the right treatment and start feeling better, sooner.
Inagene Diagnostics Inc. and dnaPower release Episode 4 of The Healthy Helix: Innovative Tools Supporting Mental Health Management
Inagene and dnaPower Launch the fourth Episode of The Healthy Helix; a series supporting education, innovation and information across the healthcare landscape.
Inagene Diagnostics raising awareness about the power of personalized pain management for all Canadians as featured on MONTRÉAL enSANTÉ magazine.
Now available on-demand: Pharmacogenomics and Personalized Medicine – The Future is Here – Pharmacy U Conference Webinar sponsored by Inagene Diagnostics
Inagene sponsors an accredited webinar with expert pharmacist John Papastergious at the Pharmacy U Vancouver Conference this past November.
Inagene Diagnostics, in partnership with dnaPower, explores health through the lens of genetics, personalized medicine and prevention to help individuals make the best decisions to live their healthiest lives in the context of COVID-19.
Inagene launches NEW Personalized Insights™ PrecisionRx: the “other test” that can help protect your health
A powerful tool for those looking to do more to protect their health in the event they are hospitalized for COVID 19 (or any other medical condition).
Inagene Diagnostics in partnership with dnaPower, take a dive deep to inform consumers how their test results can be transformative in achieving their best health
Inagene Diagnostics launches a series of videos and podcasts to create an engaging platform for consumers to understand the benefits of DNA testing
Canadian Pain Society Webinar Highlights the Promise of Pharmacogenetics for Personalized Pain Medicine
Inagene Diagnostics Inc. is proud to attend the Canadian Pain Society webinar co-presented by our Chief Science Advisor, Katherine Siminovitch on November 10th
Women are at Higher Risk for Certain Pain and Mental Health Conditions, and Experience Pain Differently Than Men: However, Everyone Can Benefit from Pharmacogenetic Testing
YMC.ca brings to light how pharmacogenetic testing can provide Canadians with a personalized roadmap to feeling better sooner.
Nancy White, CEO of Inagene Diagnostics participated in a Panel Discussion at the 20th Annual Healthcare Summit (October 26-27, 2020), which focused on how COVID-19 is changing the private and public healthcare sector, both in terms of impacts as well as opportunities.
Inagene Diagnostics Inc. had the pleasure of attending and proudly sponsoring the Pain Society of Alberta’s Virtual Pain Conference – a history making event as, with over 4200 Registrants, it was the largest pain conference in Canada’s history!
Pharmacogentic testing to Improve Patient Mental Health Outcomes During a Pandemic | A publication of The Ontario Pharmacists Association
Pharmacogenetics is a valuable tool to support mental health treatment decisions for Canadians affected by the Pandemic.
Inagene Diagnostics Inc is excited to announce a new partnership with dnaPower Inc., a fellow Canadian company, specializing in applying the power of genetics to help individuals make better, data driven decisions, about their health!
By: Karen Adams, Healthcare Advisor, Optimize Care Inc. COVID 19 has changed all of our lives in many respects, including creating a heightened focus on the value of maintaining the health, safety, and wellness of our society. Now, more than ever, we are conscious of any factors that may put our health at heightened risk, and increased focus is being placed on designing our healthcare system to be easy and safe for all to navigate.
YummyMummy Club guest author reflects on her families difficult journey with opioid dependence, and shares her hope that pharmacogenetics can help more people avoid drug dependency and painful medication side effects.
Pharmacist Nita Lakhani highlights Pharmacogenetic testing as an innovative value added service pharmacists are well positioned to offer.